NCT00180492View on ClinicalTrials.gov

Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE

NACompletedINTERVENTIONAL
Enrollment

1,500

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

August 31, 2007

Conditions
Atherosclerotic Disease, Carotid
Interventions
DEVICE

RX ACCULINK(TM) Carotid Stent System and RX ACCUNET(TM) Embolic Protection System

Trial Locations (1)

95054

Guidant Corporation, Santa Clara

Sponsors

Collaborators (1)

Guidant Corporation
All Listed Sponsors
collaborator

Guidant Corporation

INDUSTRY

lead

Abbott Medical Devices

INDUSTRY

NCT00180492 - Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE | Biotech Hunter | Biotech Hunter